Anti-α-Glucosidase Activity of Anacardic Acids from Cashew Nut Shell Liquid
Author Information
Author(s): da Silva Ana Priscila Monteiro, da Silva Gisele Silvestre, Oiram Filho Francisco, Silva Maria Francilene Souza, Zocolo Guilherme Julião, de Brito Edy Sousa
Primary Institution: Embrapa Agroindústria Tropical, Fortaleza, Brazil
Hypothesis
Can anacardic acids from cashew nut shell liquid effectively inhibit α-glucosidase?
Conclusion
Anacardic acids from cashew nut shell liquid are promising inhibitors of α-glucosidase, with the monoene variant showing the strongest effect.
Supporting Evidence
- Monoene anacardic acid (AAn1) had the strongest inhibitory effect with an IC50 of 1.78 μg/mL.
- All anacardic acids significantly outperformed acarbose, a standard diabetes medication.
- In silico docking suggested that polar groups on the aromatic ring are key for enzyme binding.
- Toxicity predictions classified anacardic acids as category IV, indicating low toxicity.
- Pharmacokinetic analysis suggested moderately favorable drug-like properties for anacardic acids.
Takeaway
This study found that certain compounds from cashew nut shells can help lower blood sugar levels by blocking an enzyme that raises glucose after meals.
Methodology
The study involved isolating anacardic acids from cashew nut shell liquid, characterizing them using NMR and MS, and testing their inhibitory effects on α-glucosidase in vitro.
Limitations
The study primarily focused on in vitro results, which may not fully represent in vivo efficacy.
Statistical Information
P-Value
p<0.0001 for AAn1 vs AAn2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website